Ablacon, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation (NCT05481359) | Ablacon, Inc. | 2022-09-12 |
| FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation (NCT06260670) | Ablacon, Inc. | 2022-09-01 |
Track Ablacon, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.